It seems that today's pr had little impact on pps but I did find a mention of the U.S. market to be interesting. The pr claims that Dr. Sharkey has meetings set up with U.S. companies concerning distribution in the U.S. Now, obviously, they can't sell even a suction ring in the U.S. without FDA approval. This begs the question of why bother with U.S. companies if FDA approval is nowhere in sight. I would think that management must have some story to tell about submitting a protocol for FDA approval. Maybe they will be looking for a distributor/partner that can aid them with putting together their protocol.
I don't want to sound overly optimistic and be labelled a pumper, but could some announcement about an FDA protocol not be too far behind an announcement about 2A--if that ever comes?
I just find it odd that they would even bother to mention U.S. distribution at this point in the game. Then again, it could be just a case of pom-pom waving to get the fans worked up into a buying mood.
Market Data 
Markets 
AI
